Design and Synthesis of 3,6-Disubstituted- and 2,3,6-Trisubstitutedquinoxalines: Docking and In Vitro Antimicrobial Study

References

• Li-Li Xu, Chang-Ji Zheng, Liang-Peng Sun, Jing Miao, and Hu-Ri Piao, “Synthesis of Novel 1,3-Diaryl Pyrazole Derivatives Bearing Rhodanine-3-Fatty Acid Moieties as Potential Antibacterial Agents,” European Journal of Medicinal Chemistry 48 (2012): 174–8.
   PubMed Web of Science ®Google Scholar
• M. S. A. El-Gaby, M. M. F. Ismail, Y. A. Ammar, M. A. Zahran, and N. A. M. M. Shmeiss, “Synthesis of Novel Quinoxaline Carboxylic Acid Derivatives for Antimicrobial Investigation,” Cheminform 33, no. 43 (2010): 1480–5.
   Google Scholar
• M. Ali, M. Ismail, M. El-Gaby, M. Zahran, and Y. Ammar, “Synthesis and Antimicrobial Activities of Some Novel Quinoxalinone Derivatives,” Molecules 5, no. 12 (2000): 864–73.
   Web of Science ®Google Scholar
• K. Aravind, A. Ganesh, and D. Ashok, “Microwave Assisted Synthesis, Characterization and Antibacterial Activity of Quinoxaline Derivatives,” Journal of Chemical and Pharmaceutical Research 5 (2013): 48–52.
   Google Scholar
• Hebat-Allah S. Abbas, Aisha R. Al-Marhabi, and Yousry A. Ammar, “Design, Synthesis and Biological Evaluation of 2, 3-Disubstituted and Fused Quinoxalines as Potential Anticancer and Antimicrobial Agents,” Acta Poloniae Pharmaceutica 74, no. 2 (2017): 445–58.
   PubMed Web of Science ®Google Scholar
• Mohamed A. El-Atawy, Ezzat A. Hamed, Mahjoba. Alhadi, and Alaa Z. Omar, “Synthesis and Antimicrobial Activity of Some New Substituted Quinoxalines,” Molecules 24, no. 22 (2019): 4198.
   Web of Science ®Google Scholar
• Shadia A. Galal, Ahmed S. Abdelsamie, Harukuni. Tokuda, Nobutaka. Suzuki, Akira. Lida, Mahmoud M. El-Hefnawi, Raghda A. Ramadan, Mona H. E. Atta, and Hoda I. El Diwani, “Part I: Synthesis, Cancer Chemopreventive Activity and Molecular Docking Study of Novel Quinoxaline Derivatives,” European Journal of Medicinal Chemistry 46, no. 1 (2011): 327–40.
   PubMed Web of Science ®Google Scholar
• Magda, M. F. Ismail, S. M. Nofal, Mohamed K. Ibrahim, Heba, S. A. El-Zahaby, and Yousry A. Ammar, “3-Ethoxycarbonylmethylene-Quinoxalin-2-One in Heterocyclic Synthesis (Part 2): Synthesis and Pharmacological Evaluation of New 6,7-Dimethylquinoxalines as Potential Nonulcerogenic anti-Inflammatory and Analgesic Agents,” Afinidad 63 (2006): 57–64.
   Google Scholar
• P. Y. Pawar, and S. B. Bhise, “Antihyperglycemic Effects of Newly Synthesized 6,7-Bis[2-(Substitutedphenyl)-4-Oxothiazolidin- 3yl] Quinoxaline 2,3-(1 H, 4 H)-Diones” Indian Journal of Physiology and Pharmacology 50 (2006): 431–4.
   PubMedGoogle Scholar
• Shivananda Wagle, Airody V. Adhikari, and Nalilu S. Kumari, “Synthesis of Some New 4-Styryltetrazolo[1,5-a]Quinoxaline and 1-Substituted-4-Styryl[1,2,4]Triazolo[4,3-a]Quinoxaline Derivatives as Potent Anticonvulsants,” European Journal of Medicinal Chemistry 44, no. 3 (2009): 1135–43.
   PubMed Web of Science ®Google Scholar
• Radhakrishnan Mahesh, Thangaraj Devadoss, Dilip K. Pandey, Shvetank Bhatt, and Shushil K. Yadav, “Design, Synthesis and Structure-Activity Relationship of Novel Quinoxalin-2-carboxamides as 5-HT3 Receptor Antagonists for the Management of Depression,” Bioorganic & Medicinal Chemistry Letters 20, no. 22 (2010): 6773–6.
   PubMed Web of Science ®Google Scholar
• Kenji Watanabe, Kinya Hotta, Mino Nakaya, Alex P. Praseuth, Clay C. C. Wang, Daiki Inada, Kosaku Takahashi, Eri Fukushi, Hiroki Oguri, and Hideaki Oikawa, “Escherichia coli Allows Efficient Modular Incorporation of Newly Isolated Quinomycin Biosynthetic Enzyme into Echinomycin Biosynthetic Pathway for Rational Design and Synthesis of Potent Antibiotic Unnatural Natural Product,” Journal of the American Chemical Society 131, no. 26 (2009): 9347–53.
   PubMed Web of Science ®Google Scholar
• Yuki Hirose, Kenji Watanabe, Atsushi Minami, Takemichi Nakamura, Hiroki Oguri, and Hideaki Oikawa, “Involvement of Common Intermediate 3-hydroxy-L-Kynurenine in Chromophore Biosynthesis of Quinomycin Family Antibiotics,” The Journal of Antibiotics 64, no. 1 (2011): 117–22.
   PubMed Web of Science ®Google Scholar
• David W. Green, “The Bacterial Cell Wall as a Source of Antibacterial Targets,” Expert Opinion on Therapeutic Targets 6, no. 1 (2002): 1–19.
   PubMedGoogle Scholar
• Lynn L. Silver, “Does the Cell Wall of Bacteria Remain a Viable Source of Targets for Novel Antibiotics?,” Biochemical Pharmacology 71, no. 7 (2006): 996–1005.
   PubMed Web of Science ®Google Scholar
• Andreja Kovac, Vita Majce, Roman Lenarsic, Sergeja Bombek, Julieanne M. Bostock, Ian Chopra, Slovenko Polanc, and Stanislav Gobec, “Diazenedicarboxamides as Inhibitors of D-alanine-D-Alanine Ligase (Ddl),”Bioorganic & Medicinal Chemistry Letters 17, no. 7 (2007): 2047–54.
   PubMed Web of Science ®Google Scholar
• Mutasem O. Taha, Naji Atallah, Amal G. Al-Bakri, Catherine Paradis-Bleau, Hiba Zalloum, Khaled S. Younis, and Roger C. Levesque, “Discovery of New MurF Inhibitors via Pharmacophore Modeling and QSAR Analysis Followed by In-Silico Screening,” Bioorganic & Medicinal Chemistry 16, no. 3 (2008): 1218–35.
   PubMed Web of Science ®Google Scholar
• Ellen Z. Baum, Steven M. Crespo-Carbone, Barbara D. Foleno, Lee D. Simon, Jerome. Guillemont, Mark. Macielag, and Karen. Bush, “MurF Inhibitors with Antibacterial Activity: Effect on Muropeptide Levels” Antimicrob,” Antimicrobial Agents and Chemotherapy 53no. 8 (2009): 3240–7.
   PubMed Web of Science ®Google Scholar
• C. L. Leese, and H. N. Rydon, “Polyazanaphthalenes. Part 1. Some Derivatives of 1:4:5-Triazanaphthalene and Quinoxaline,” Journal of the Chemical Society (Resumed) (1955): 303–8.
   Google Scholar
• Hirotaka Otomasu, and Shoichi Nakajima, “On the Nitration of Quinoxalines,” Chemical & Pharmaceutical Bulletin 6, no. 5 (1958): 566–70.
   Google Scholar
• J. B. Rather, and E. Emmet Reid, “The Identification of Acids. IV. Phenacyl Esters,” Journal of the American Chemical Society 41, no. 1 (1919): 75–83.
   Google Scholar
• R. R. Dangi, N. Hussain, A. Joshi, G. Pemawat, and G. L. Talesara, “Design, Facile Synthesis and Biological Evaluation of Quinazoline Containing Pyrazolothiazolyl, Triazinone and Their Ethoxyphthalimide Derivatives” Indian Journal of Chemistry 43, no. 4 (2012): 1165–72.
   Google Scholar
• Mohga M. Badran, Ashraf A. Moneer, Hanan M. Refaat, and Afaf A. El-Malah, “Synthesis and Antimicrobial Activity of Novel Quinoxaline Derivatives,” Journal of the Chinese Chemical Society 54, no. 2 (2007): 469–78.
   Web of Science ®Google Scholar
• Lippmann Eberhard, and Burckhardt Helmut, “Quinoxalines. XX. Synthesis and Reactions of 6-Nitroquinoxalines,” Zeitschrift fuer Chemie 25 (1985): 431.
   Google Scholar
• Ashish K. Nanda, Subarna Ganguli, and Ranadhir Chakraborty, “Antibacterial Activity of Some 3-(Arylideneamino)-2-Phenylquinazoline-4(3H)-Ones: Synthesis and Preliminary QSAR Studies,” Molecules (Basel, Switzerland) 12, no. 10 (2007): 2413–26.
   PubMed Web of Science ®Google Scholar
• Hirotaka Otomasu, and K. Yoshida, “On the Nitration of Quinoxalines (Addendum),”Chemical & Pharmaceutical Bulletin 8, no. 5 (1960): 475–8.
   Google Scholar
• Abdulrahman M. Al-Obaid, Sami G. Abdel-Hamide, Hassan A. El-Kashef, Alaa A.-M. Abdel-Aziz, Adel S. El-Azab, Hamad A. Al-Khamees, and Hussein I. El-Subbagh, “Substituted Quinazolines, Part 3. Synthesis, in Vitro Antitumor Activity and Molecular Modeling Study of Certain 2-Thieno-4(3H)-Quinazolinone Analogs,” European Journal of Medicinal Chemistry 44, no. 6 (2009): 2379–91.
   PubMed Web of Science ®Google Scholar
• Sayed M. Riyadh, “Enaminones as Building Blocks for the Synthesis of Substituted Pyrazoles with Antitumor and Antimicrobial Activities,” Molecules (Basel, Switzerland) 16, no. 2 (2011): 1834–53.
   PubMed Web of Science ®Google Scholar
• Abdel, Zaher A. Elassar, “Novel Synthesis of Dihydroquinoxalinylpyridazine Derivatives,” Journal of the Chinese Chemical Society 53, no. 4 (2006): 901–7.
   Web of Science ®Google Scholar
• Kenton L. Longenecker, Geoffrey F. Stamper, Philip J. Hajduk, Elizabeth H. larissa G. Jakob, John E. Harlan, Rohention. Edalji, Diane M. Bartley, Karl A. Walter, Larry R. Solomon, Thomas F. Holzman, et al. “Structure of MurF from Streptococcus pneumoniae co-Crystallized with a Small Molecule Inhibitor Exhibits Interdomain Closure,” Protein Science 14, no. 12 (2005): 3039–47.
   PubMed Web of Science ®Google Scholar
• Atta-ur-Rahman, M. Iqbal Choudhary, and William J. Thomsen, Bioassay Techniques for Drug Development (Amsterdam, The Netherlands: Harwood Academic Publishers, 2001), 16.
   Google Scholar
• Sonia. Damyanova, Lewis M. Gomez, Miguel A. Banares, and Jose L. G. Fierro, “Thermal Behavior of 12-Molybdophosphoric Acid Supported on Zirconium-Loaded Silica,”Chemistry of Materials 12, no. 2 (2000): 501–10.
   Web of Science ®Google Scholar